Mahzi Therapeutics
Rare Disease Therapeutics | Home
United States · $30.8M raised
- Business Model
- B2B
- Website
- mahzi.com
- Total Funding
- $30.8M
- Last Round
- $4.0M GrantJun 2024
- Rounds
- 2
About
Clinical-stage biotechnology company developing gene therapy and ASO-based precision therapies for rare genetic neurodevelopmental disorders.
Summary
Mahzi Therapeutics is a Biotech company based in United States. It has raised $30.8M in total across 2 rounds, most recently a $4.0M Grant round in Jun 2024.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...